Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.

Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision tag v3.6.3 was added and the old v3.6.0 tag was removed, signaling an updated page revision.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardized the Intervention/Treatment heading while removing the previous Intervention / Treatment label; updated the revision line from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check32 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, indicating an internal update to the page without changes to study information.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision label on the study page was updated from v3.5.3 to v3.5.4. This represents a minor update to the record and does not modify the trial details or eligibility criteria.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page’s footer/version label was updated from Revision: v3.5.2 to Revision: v3.5.3, indicating a minor site release change rather than a content change to the clinical trial record.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.